Screening and Intervention for AIS in Haikou, Hainan Province, China

August 1, 2023 updated by: Chaoyin Jiang

Screening and Intervention for Adolescent Idiopathic Scoliosis in Haikou, Hainan Province, China

This is a single-center, prospective, non-randomized, open-label, interventional, real-world study. The mild/moderate AIS patients will be recruited through screening of 250,000 primary and secondary school students in Haikou, Hainan Province. The patients will be treated with different non-surgical interventions (exercise intervention or brace intervention) according to the physician's recommendations and the patient's intention. Patients will be followed up for 36 months to evaluate the effectiveness and safety of non-surgical interventions in the real world.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

5000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Hainan
      • Haikou, Hainan, China, 570300
        • Recruiting
        • Haikou orthopedic and diabetes hospital, Haikou orthopedic and diabetes hospital of Shanghai Sixth People's Hospital
        • Contact:
          • Chaoyin Jiang, MD
        • Principal Investigator:
          • Chaoyin Jiang, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

9 years to 16 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. 9 years ≤ age ≤ 16 years
  2. Diagnosis of AIS
  3. 10°≤Cobb's angle<45°
  4. Signed informed consent form

Exclusion Criteria:

  1. With other developmental disorders, musculoskeletal disorders, nerve disorders, infection disorders, mental disorders, and other disorders
  2. Obvious deformity of lower limbs and(or) feet
  3. Previous or ongoing treatment of AIS
  4. Difficulty to read, understanding, and complete the study questionnaires
  5. Any criteria, which, in the opinion of the investigator, suggest that the subject would not be compliant with this study protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: recommend exercise - perference exercise
Exercise rehabilitation with Schroth method
Active Comparator: recommend exercise - perference brace
Wear an orthopedic brace
No Intervention: recommend exercise - perference observation
Active Comparator: recommend brace - perference brace
Wear an orthopedic brace
Active Comparator: recommend brace - perference exercise
Exercise rehabilitation with Schroth method
No Intervention: recommend brace - perference observation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Out-of-control rate of treatment
Time Frame: 36 months
Among the patients with skeletal immaturity (Risser's sign 0, 1, 2), out-of-control rate of treatment at the follow-up to 36 months or at skeletal maturity during the trial (i.e., 4° for female Risser's sign or 5° for male Risser's sign). Out-of-control rate of treatment is defined as either: Cobb angle progression >5°, or Cobb angle ≥45°, or the physician recommends or already has enhanced the intervention regimen (i.e., no intervention change to exercise intervention, no intervention change to brace intervention, or exercise intervention change to brace intervention).
36 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of adverse events
Time Frame: 36 months
The incidence of adverse events for the intervention
36 months
Change in SRS-22 score from baseline over time
Time Frame: at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Change in quality of life (SRS-22 score) from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment
at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Change in vital capacity from baseline over time
Time Frame: at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Change in vital capacity from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment.
at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Change in plantar pressure from baseline over time
Time Frame: at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Change in plantar pressure from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, and 36 months after treatment compared with those before treatment.
at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Change in gait from baseline over time
Time Frame: at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Change in gait from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment
at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment
Correlation between the treatment compliance and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the treatment compliance (average daily duration of treatment for scoliosis) and the out-of-control rate of treatment
36 months
Correlation between the skeletal maturity at baseline and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the skeletal maturity (Risser's sign) at baseline and the out-of-control rate of treatment
36 months
Correlation between the Cobb's angle at baseline and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the Cobb's angle at baseline and the out-of-control rate of treatment
36 months
Correlation between the immediate correction and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the immediate correction [(the baseline of Cobb angle - Cobb angle immediately after wearing the brace)/the baseline of Cobb angle] and the out-of-control rate of treatment
36 months
The change in Cobb angle from baseline over time
Time Frame: 36 months
The change in Cobb angle from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment
36 months
Correlation between the treatment compliance and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the treatment compliance (average daily duration of treatment for scoliosis) and the change in 36-month Cobb angle from baseline
36 months
Correlation between the skeletal maturity at baseline and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the skeletal maturity (Risser's sign) at baseline and the change in 36-month Cobb angle from baseline
36 months
Correlation between the immediate correction and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the immediate correction [(the baseline of Cobb angle - Cobb angle immediately after wearing the brace)/the baseline of Cobb angle] and the change in 36-month Cobb angle from baseline
36 months
Correlation between the Cobb's angle at baseline and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the Cobb's angle at baseline and the change in 36-month Cobb angle from baseline
36 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation between the age and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the patient's age and the out-of-control rate of treatment
36 months
Correlation between the BMI at baseline and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the patient's BMI (kg/m^2) at baseline and the out-of-control rate of treatment
36 months
Correlation between the type of AIS and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the type of AIS and the out-of-control rate of treatment
36 months
Correlation between the types of braces and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the types of braces and the out-of-control rate of treatment
36 months
Correlation between the average time spent doing homework per day at baseline and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the average time (hours) spent doing homework per day at baseline and the out-of-control rate of treatment
36 months
Correlation between the vitamin D content at baseline and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the serum 25(OH)D (nmol/L) at baseline and the out-of-control rate of treatment
36 months
Correlation between the average time spent doing outdoor exercise after school per day at baseline and the out-of-control rate of treatment
Time Frame: 36 months
Correlation between the average time (hours) spent doing outdoor exercise after school per day at baseline and the out-of-control rate of treatment
36 months
Correlation between the age and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the patient's age and the change in 36-month Cobb angle from baseline
36 months
Correlation between the BMI at baseline and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the patient's BMI (kg/m^2) at baseline and the change in 36-month Cobb angle from baseline
36 months
Correlation between the type of AIS and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the type of AIS and the change in 36-month Cobb angle from baseline
36 months
Correlation between the types of braces and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the types of braces and the change in 36-month Cobb angle from baseline
36 months
Correlation between the average time spent doing homework per day at baseline and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the average time (hours) spent doing homework per day at baseline and the change in 36-month Cobb angle from baseline
36 months
Correlation between the vitamin D content at baseline and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the serum 25(OH)D (nmol/L) at baseline and the change in 36-month Cobb angle from baseline
36 months
Correlation between the average time spent doing outdoor exercise after school per day at baseline and the change in 36-month Cobb angle from baseline
Time Frame: 36 months
Correlation between the average time (hours) spent doing outdoor exercise after school per day at baseline and the change in 36-month Cobb angle from baseline
36 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 24, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

July 18, 2022

First Submitted That Met QC Criteria

July 19, 2022

First Posted (Actual)

July 20, 2022

Study Record Updates

Last Update Posted (Actual)

August 4, 2023

Last Update Submitted That Met QC Criteria

August 1, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • GTYN2022001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on AIS

Clinical Trials on Exercise

3
Subscribe